Vasoactive intestinal peptide: a potential target for antiviral therapy.

He, Yu; Zang, Na; Liu, En-Mei

He, Yu; Zang, Na; Liu, En-Mei.

Afiliação

He Y; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400014, China.
Zang N; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400014, China.
Liu EM; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400014, China. emliu186@126.com.

Sheng Li Xue Bao ; 74(3): 419-433, 2022 Jun 25.

Article em En | MEDLINE | ID: mdl-35770640

Assuntos

Tratamento Farmacológico da COVID-19; Infecção por Zika virus; Zika virus; Antivirais/uso terapêutico; Humanos; Estudos Prospectivos; SARS-CoV-2; Peptídeo Intestinal Vasoativo/uso terapêutico; Infecção por Zika virus/tratamento farmacológico

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zika virus / Infecção por Zika virus / Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Sheng Li Xue Bao Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links